Trial Details
RECRUITINGBasic Information
| Clinical ID | c1473 |
|---|---|
| Identifier | NCT03221036 |
| Trial Title | Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Moderately to Severely Active Ulcerative Colitis |
| Interventions | DRUG: Vedolizumab IV|DRUG: Placebo |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Hefei |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2017-08-03 |
|---|---|
| Primary Completion Date | 2028-05-23 |
| Completion Date | 2028-07-18 |